Resources

Glucokinase MODY: Glucokinase catalyzes the phosphorylation of glucose to glucose-6-phosphate. Its unique kinetic properties result in the rate of glucose phosphorylation being proportional to the physiologic glucose concentration. This means that the beta cell and hepatocyte can respond appropriately to fluctuations in the degree of glycemia. In the pancreatic beta cell, glucokinase acts as “the glucose sensor” ensuring insulin release is appropriate to the blood glucose concentration.

In this Exclusive Interview transcript, Judith Wylie-Rosett talks with Diabetes in Control publisher Steve Freed during the ADA 2018 convention in Orlando about non-nutritive sweetener safety and uses, and the effect of low-calorie, sweetened beverages on cardiometabolic health.

In this Exclusive Interview, Judith Wylie-Rosett talks with Diabetes in Control publisher Steve Freed during the ADA 2018 convention in Orlando about the use of low-calorie, sweetened beverages on cardiometabolic health.

In part 1 of this Exclusive Interview, Judith Wylie-Rosett talks with Diabetes in Control Publisher Steve Freed about the safety of non-nutritive sweeteners.

In part 2 of this Exclusive Interview, Judith Wylie-Rosett talks with Diabetes in Control Publisher Steve Freed about the various users of low calorie sweeteners.

In part 3 of this Exclusive Interview, Judith Wylie-Rosett shares the results of trials studying the effects of using sweeteners in a conversation with Diabetes in Control Publisher Steve Freed.

In part 4 of this Exclusive Interview, Judith Wylie-Rosett talks with Diabetes in Control Publisher Steve Freed about the impact of artificial sweeteners on weight loss efforts as well as cardiometabolic health.

In part 5, the conclusion of this Exclusive Interview, Judith Wylie-Rosett talks with Diabetes in Control Publisher Steve Freed about her recommendations regarding talking about the use of sweeteners with patients who have diabetes. She also shares the highlights of her ADA presentation.

Diabetes in Control readers are being asked to participate in exclusive research that will provide new insights into what you think about insulin pumps and daily injections. Whether you’re a patient, a patient family member, medical professional or diabetes educator, we need to hear from you. Please take a few moments to take our survey and help our research. The survey takes only about 3 minutes, is completely anonymous, and lets you make your voice heard in analysis that can potentially influence the future of insulin delivery research and development.

The beta-cell preserving properties of short courses of metformin and insulin glargine evaluated in ever-growing population of patients who have diabetes.